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Background: The aim of this study was to compare the agreement between spectral domain 
optical coherence tomography (SD OCT) and time domain stratus OCT (TD OCT) in evaluating 
macular morphology alterations in wet age-related macular degeneration (AMD).
Methods: This retrospective study was performed on 77 eyes of 77 patients with primary or 
recurring subfoveal choroidal neovascularization secondary to AMD. All patients underwent 
OCT examination using Zeiss Stratus OCT 3 (Carl Zeiss Meditec Inc, Dublin, CA) and Opko 
OTI Spectral SLO/OCT (Ophthalmic Technologies Inc, Toronto, Canada). In all radial line 
scans, the presence of intraretinal edema (IRE), serous pigment epithelium detachment (sPED), 
neurosensory serous retinal detachment (NSRD), epiretinal membrane (EM), inner limiting 
membrane thickening (ILMT), and hard exudates (HE) were evaluated. The degree of matching 
was quantified by Kappa measure of agreement.
Results: The percentage distribution of TD OCT findings versus SD OCT findings was: 
IRE 36.3% versus 77.9%, sPED 57.1% versus 85.7%, NSRD 38.9% versus 53.2%, EM 10.5% 
versus 26.3%, ILMT 3.8% versus 32.4%, and HE 6.4% versus 54.5%. The agreement was as 
follows: sPED: kappa value 0.15; NSRD: kappa value 0.61; IRE: kappa value 0.18; EM: kappa 
value 0.41; ILMT: kappa value 0.02; HE: kappa value 0.06.
Conclusion: The agreement in the evaluation of macular lesions between the two techniques 
is poor and depends on the lesion considered. SD OCT allows better detection of the alterations 
typically related to choroidal neovascularization such as IRE, PED, ILM thickening, and HE. 
Consequently its use should be strongly considered in patients with wet AMD.
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Introduction
Although fluorescein angiography remains fundamental in determining the presence 
of choroidal neovascularization (CNV), many recent studies include optical coher-
ence tomography (OCT) to investigate the severity of exudative macular pathologies, 
to evaluate the possibility of retreatment, and to monitor the response to anti VEGF 
therapy during follow up.1–3
In recent years the development of high-speed detection techniques (such as spectral 
domain [SD] OCT) has led to a significant improvement in OCT imaging performance, 
providing more detailed information on intraretinal morphology with respect to the 
first generation time domain (TD) OCT.4–9
The aim of this study was to assess the agreement between SD OCT and 
TD OCT in evaluating the CNV-related alterations in wet age-related macular 
  degeneration (AMD).
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Materials and methods
This retrospective observational study was performed 
on 77 eyes of 77 patients (34 men, 43 women, mean age 
74.3 ± 9.7 years) affected by wet AMD attending our 
department between June and December 2009. The research 
adhered to the tenets of the declaration of Helsinki. All 
patients signed a written consent to permit the use of the 
images for this study. In order to qualify for the study, the 
patients were required to have primary or recurring subfo-
veal CNV secondary to AMD. Exclusion criteria were other 
types of CNV and the coexistence of any other macular 
diseases.
All patients underwent OCT examination using two 
OCT devices: TD OCT (Stratus OCT 4.0.1, Carl Zeiss 
  Meditec Inc, Dublin, CA) and SD OCT (OCT/SLO Opko/
OTI,   Ophthalmic Technologies Inc, Toronto, Canada). TD 
OCT uses a   near-infrared frequency light of 820 nm, with 
an axial resolution of 10 µm and speed of 400 A-scans/sec. 
The light source of the SD OCT/SLO OTI is a modified 
super luminescent diode at a wavelength of 840 nm. The 
axial resolution is 5 µm and the transverse is 16 µm. The 
speed is set at 28000 A-scan/sec; every B-scan is composed 
of 512 A-scans. The OCT is coupled to a scanning laser 
ophthalmoscope (SLO). A single experienced examiner 
performed the OCT examinations with a standard protocol 
for the two tools on the same day. Using the TD OCT and the 
SD OCT every eye in this study underwent the radial lines 
acquisition protocol after centering the scans on the fovea. 
If doubt about the presence or the nature of a lesion aroused, 
a single radial scan was used by the examiner to move the 
scan and investigate the lesion itself. The images were then 
recorded on the OCT computer and subsequently observed 
and analyzed using display intrinsic to TD OCT and SD 
OCT by two independent experienced examiners unaware 
of the purpose of the research who evaluated the presence 
of intraretinal edema (IRE), serous pigment epithelium 
detachment (PED), neurosensory serous retinal detachment 
(NSRD), epiretinal membrane (EM), inner limiting mem-
brane thickening (ILMT), and hard exudate deposition (HE). 
Possible disagreement was resolved after discussion, so that 
investigators agreed on all the images.
IRE was defined as a diffuse or localized hyporeflective 
area inside the neuroretina. PED was characterized as a 
dome-shaped lesion of the retinal pigment epithelium layer. 
NSRD showed up as a hyporeflective area between the retinal 
pigment epithelium and all the superior retina layers, and EM 
was consistent with a high reflective line on the inner layer 
of the retina. ILMT was viewed as a high reflective band 
between the vitreous and the retinal layers. HE was revealed 
as high reflective round or oval intraretinal lesions.
The extent of the match between the two   evaluations 
was quantified by the Kappa measure of agreement. 
The   Chi-square was used to evaluate links between the 
parameters.
Results
The percentage of distribution is listed in Table 1. In 
  particular, IRE was detected by TD OCT in 28 eyes 
(36.3%) and by SD OCT in 60 eyes (77.9%). PED was 
discovered by TD OCT in 44 eyes (57.1%) and by SD 
OCT in 66 eyes (85.7%). NSRD was shown by TD OCT 
in 30 eyes (38.9%) and by SD OCT in 41 eyes (53.2%). 
EM was evidenced by TD OCT in 8 eyes (10.5%) and by 
SD OCT in 20 eyes (26.3%). ILMT was visualized by TD 
OCT in 3 eyes (3.8%) and by SD OCT in 25 eyes (32.4%). 
HE was identified by TD OCT in 5 eyes (6.4%) and by SD 
OCT in 42 eyes (54.5%).
The agreement rate for each OCT feature is reported 
in Table 2. More specifically, the presence of PED: kappa 
value 0.15; presence of NSRD: kappa value 0.61; presence 
of IRE: kappa value 0.18; presence of EM: kappa value 0.41; 
presence of ILMT: kappa value 0.02; presence of HE: 
kappa value 0.06.
Discussion
OCT has become increasingly useful in the diagnosis and 
the treatment of AMD. The recent advent of SD OCT has 
increased the hope to obtain a more reliable tool in an attempt 
to define the changes in CNV activity5,10–14 and, consequently, 
the possible retreatment.3 Also, OCT can provide quantitative 
and qualitative information regarding CNV-related features, 
and the introduction of SD technology has led to a remarkable 
improvement in lesion imaging due to improved definition 
of the scanned images.5,10–14
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Table 1 Percentage distribution of the lesions
TD OCT SD OCT
IRE 36.3% 77.9%
sPED 57.1% 85.7%
nSRD 38.9% 53.2%
EM 10.5% 26.3%
ILMT 3.8% 32.4%
hE 6.4% 54.5%
Abbreviations:  TD  OCT,  time  domain  optical  coherence  tomography; 
SD OCT, spectral domain optical coherence tomography; IRE, intraretinal edema; 
sPED, serous pigment epithelium detachment; nSRD, neurosensory serous retinal 
detachment; EM, epiretinal membrane; ILMT, inner limiting membrane thickening; 
hE, hard exudates.Clinical Ophthalmology 2012:6
The two generations of OCT, TD and SD, have been 
largely investigated in order to evaluate repeatability and 
reproducibility of the examinations in many macular diseases, 
but the varying patterns of exudation secondary to AMD 
make OCT examination difficult to compare when performed 
with the same or more instruments. In fact some authors 
compared TD and SD macular thickness measurements 
findings obtained in different sessions and questioned the 
repeatability of the results.15–18 It has also been demonstrated 
by Giani et al that retinal thickness measurements obtained 
by various OCT devices such as Stratus and Cirrus (Carl 
Zeiss Meditech Inc), Spectralis (Heidelberg   Engineering 
Inc, Heidelberg, Germany) and 3D-OCT-1000 (Topcon 
Corporation, Tokyo, Japan) are different due to the analysis 
algorithms used to set retinal inner and outer boundaries.18 
Nevertheless, Eriksson et al recently suggested the use of 
software for manual correction of foveal position when 
using Cirrus SD OCT (Carl Zeiss Meditech Inc) to reduce 
the variability of the measurements.19
As a consequence, we decided not to compare the 
macular thickness findings but to evaluate the presence/
absence of AMD-related typical lesions when investigated 
by different generations of OCT. So far, to our knowledge, 
only Sayanagi et al compared the ability to delineate patterns 
of CNV   activity using Stratus OCT and four different SD 
OCT devices, concluding that all SD OCT were statistically 
superior to delineate IRE presence.20 Therefore, it is not 
surprising that our study found that IRE was undetected by 
TD OCT in 32 patients (41%). This is of great relevance as 
IRE is considered the key factor in treatment and retreatment 
decisions,3 and most of the authors assess the lesions 
persistent activity if intraretinal fluid is present.
No other studies investigated the relative sensitivity of 
TD and SD OCT in identifying the single lesions typically 
related to CNV presence, and overall our results reveal a 
poor agreement. Indeed, some concordance between the 
two instruments can be found only in the identification 
of NSRD (kappa value 0.61) and EM (kappa value 0.41), 
but concordance was poor in the evaluation of IRE, PED, 
ILMT, and HE, where kappa value was always less than 
0.2. These results may hint that the smaller lesions are more 
clearly identified by SD OCT (Figure 1). In fact SD OCT, due 
to its improved resolution and scan acquisition, enables the 
smaller structures in all the retinal layers to be visualized, in 
particular the internal and external limiting membrane, the 
inner segment/outer segment of the photoreceptors, and in 
some cases the Bruch’s membrane.11–13
A good match between the two tools has been registered only 
with respect to NSRD, probably because the fluid between the 
retinal pigment epithelium and the neuroretina is clearly serous 
and hyporeflective, and consequently can be easily detectable 
by both techniques. The moderate and slight agreement in 
detecting EM and ILM thickening, respectively, suggests that 
SD OCT more reliably detects these alterations, because of 
more sensitivity in visualizing the vitreomacular interface 
alterations, as already highlighted by some authors.21–23
This aspect could lead to better interpret the specific 
role of vitreomacular adhesions in the development of 
CNV, which has been postulated to have an active role 
by some authors24 but, more recently not by others.25 Our 
  findings, that evidenced 26% to 32% of eyes   presenting 
with EM or ILM, respectively, at SD OCT, overall 
resemble the data reported by Mojana et al that included 
a series of 170 eyes of which 27.8% had vitreomacular 
adhesion.26 In that study some patients underwent   macular 
Table 2 Kappa measure of agreement between TD OCT and 
SD OCT
Kappa value
IRE 0.18
sPED 0.15
nSRD 0.61
EM 0.41
ILMT 0.02
hE 0.06
Abbreviations: TD OCT, time domain optical coherence tomography; SD OCT, 
spectral domain optical coherence tomography; IRE, intraretinal edema; sPED, serous 
pigment epithelium detachment; nSRD, neurosensory serous retinal detachment;   
EM, epiretinal membrane; ILMT, inner limiting membrane thickening; hE, hard exudates.
A
B
Figure 1 (A) Macular horizontal line scan by time domain (TD) OCT. (B) Macular 
horizontal line scan by spectral domain (SD) OCT. The comparison between the two 
OCT tools points out that hard exudates (white arrow) are visualized only by the 
SD device, where also intraretinal fluid cysts appear more evident and numerous.
Abbreviation: OCT, optical coherence tomography.
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peeling and they concluded that tractional forces may 
antagonize the effect of anti-VEGF treatment, and cause 
pharmacological resistance in a subpopulation of patients. 
Consequently we think the possibility of detecting initial 
thickening of vitreoretinal interface could also have some 
prognostic relevance.
A surprising assumption of our study is that hard exu-
dates were visible in 54.5% of eyes when investigated by SD 
OCT versus only 6.4% by TD OCT. This great difference 
is evidently due to the greater sensitivity of SD technology, 
but could also lead to misdiagnosis as hyperreflective points 
could correspond to retinal vessels or punctate hemorrhages 
not visible by TD OCT. Tomographic characteristics must 
assist the clinician in proper diagnosis; this could prove 
difficult in some circumstances such as the interpretation 
of small pseudocysts that can masquerade as outer retina 
tubulation caused by photoreceptors arrangement during 
late stages of exudative AMD.27 It appears evident that better 
diagnostic capabilities allowed by SD OCT require better 
operator abilities, as the detection of fine morphological 
aspects expand the spectrum of the corresponding retinal 
details identification.
Conclusion
In conclusion, our findings suggest that SD OCT can better 
disclose a large number of retinal lesions of various types, 
indicating a clear advantage in the detection of tiny abnor-
malities of the retinal morphology.
The agreement in the evaluation of macular lesions 
between the two techniques is poor and depends on the lesion 
considered. SD OCT allows better detection of the alterations 
typically related to CNV such as IRE, PED, ILM thickening, 
and HE. Consequently its use should be strongly considered 
in patients with wet AMD.
Disclosure
The authors report no conflicts of interest in this work.
References
1.  Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence 
tomography-guided, variable dosing regimen with intravitreal ranibi-
zumab (Lucentis) for neovascular age-related macular degeneration.   
Am J Ophthalmol. 2007;143:566–583.
2.  Gupta OP, Shienbaum G, Patel AH, Fecarotta C, Kaiser RS, Regillo CD.   
A treat and extend regimen using ranibizumab for neovascular age-related 
macular degeneration clinical and economic impact. Ophthalmology. 
2010;117:2134–2140.
3.  Lalwani GA, Rosenfeld PJ, Fung AE, et al. A variable-dosing regimen 
with intravitreal ranibizumab for neovascular age-related macular 
degeneration: year 2 of the PrONTO study. Am J Ophthalmol. 2009; 
148:43–58.
  4.  Ko TH, Fujimoto JG, Schuman JS, et al. Comparison of ultrahigh- and 
standard-resolution optical coherence tomography for imaging macular 
pathology. Ophthalmology. 2005;112:1922–1915.
  5.  Chen Y, Vuong LN, Liu J, et al. Three-dimensional ultrahigh resolu-
tion optical coherence tomography imaging of age-related macular 
degeneration. Opt Express. 2009;17:4046–4060.
  6.  Keane PA, Bhatti RA, Brubaker JW, Liakopoulus S, Sadda SR, Walsh AC.   
Comparison of clinically relevant findings from high-speed Fourier-
domain and conventional time-domain optical coherence tomography. 
Am J Ophthalmol. 2009;148:242–248.
  7.  Drexler W, Fujimoto JG. State-of-the-art retinal optical coherence 
tomography. Prog Ret Eye Res. 2008;27:45–88.
  8.  Wojtkowski M, Srinivasan V , Fujimoto JG, et al. Three-dimensional 
retinal imaging with high-speed ultra-high resolution optical coherence 
tomography. Ophthalmology. 2005;112:1734–1746.
  9.  Drexler W. Ultrahigh-resolution optical coherence tomography.   
J Biomed Opt. 2004;9:47–74.
  10.  Coscas G, Coscas F, Vismara S, Souied E, Soubrane G. Spectral Domain 
OCT in age-related macular degeneration: preliminary results with 
Spectralis HRA-OCT. J Fr Ophthalmol. 2008;31:353–361.
  11.  Brennen PM, Kagemann L, Friberg TR. Comparison of stratus OCT 
and cirrus HD-OCT imaging in macular diseases. Ophthalmic Surg 
Lasers Imaging. 2009;40:25–31.
  12.  Menke MN, Dabov S, Sturm V. Features of age-related macular 
degeneration assessed with three-dimensional Fourier-domain optical 
coherence tomography. Br J Ophthalmol. 2008;92:1492–1497.
  13.  Schmidt-Erfurth U, Leitbeg RA, Michels S, et al. Three-dimensional 
ultra-high resolution optical coherence tomography of macular diseases. 
Invest Ophthalmol Vis Sci. 2005;46:3393–3402.
  14.  Cukras C, Wang YD, Meyerle CB, Forooghian F, Chew EY, Wong WT.   
Optical coherence tomography-based decision making in exudative 
age-related macular degeneration: comparison of time- versus spectral-
domain devices. Eye. 2009;24:775–783.
  15.  Parravano M, Oddone F, Boccassini B, et al. Reproducibility of 
macular thickness measurements using Cirrus SD-OCT in neovas-
cular age-related macular degeneration. Invest Ophthalmol Vis Sci. 
2010;51:4788–4791.
  16.  Patel PJ, Chen FK, Ikeji F, Tufail A. Intersession repeatability of optical 
coherence tomography measures of retinal thickness in early age-related 
macular degeneration. Acta Ophthalmol. 2011;89:229–234.
  17.  Patel PJ, Chen FK, Ikeji F, Richardson M, Cruz LD, Tufail A. Intrasession   
repeatability of optical coherence tomography measures in active 
neovascular age-related macular degeneration. Acta Ophthalmol. 
2009;89:526–532.
  18.  Giani A, Cigada M, Choudhry N, et al. Reproducibility of retinal thickness 
measurements on normal and pathologic eyes by different optical coherence   
tomography instruments. Am J Ophthalmol. 2010;150:815–824.
  19.  Eriksson U, Alm A, Larsson E. Is quantitative spectral-domain superior 
to time-domain optical coherence tomography (OCT) in eyes with age-
related macular degeneration? Acta Ophthalmol. 2011; doi:10.1111/j. 
1755-3768.2011.02112.x.
  20.  Sayanagi K, Sharma S, Yamamoto T, Kaiser PK. Comparison of 
spectral-domain versus time-domain optical coherence tomography in 
management of age-related macular degeneration with ranibizumab. 
Ophthalmology. 2009;116:947–955.
  21.  Koizumi H, Spaide RF, Fisher YL, Freund KB, Klancnik JM Jr,   
Yannuzzi LA. Three-dimensional evaluation of vitreomacular traction 
and epiretinal membrane using spectral-domain optical coherence 
tomography. Am J Ophthalmol. 2008;145:509–517.
  22.  Legaretta JE, Gregori G, Knighton RW, Punjabi OS, Lalwani GA, 
Puliafito CA. Three-dimensional spectral-domain optical   coherence 
tomography images of the retina in the presence of epiretinal 
  membranes. Am J Ophthalmol. 2008;145:1023–1030.
  23.  Michalewski J, Michalewska Z, Cisiecki S, Nawrocki J. Morphologically 
functional correlations of macular pathology connected with epiretinal 
membrane formation in spectral optical coherence tomography. (SOCT). 
Graefes Arch Clin Exp Ophthalmol. 2007;245:1623–1631.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
222
Pierro et alClinical Ophthalmology
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/clinical-ophthalmology-journal
Clinical Ophthalmology is an international, peer-reviewed journal 
covering all subspecialties within ophthalmology. Key topics include: 
Optometry; Visual science; Pharmacology and drug therapy in eye 
diseases; Basic Sciences; Primary and Secondary eye care; Patient 
Safety and Quality of Care Improvements. This journal is indexed on 
PubMed Central and CAS, and is the official journal of The Society of 
Clinical Ophthalmology (SCO). The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
Clinical Ophthalmology 2012:6
  24.  Lee SJ, Lee CS, Koh HJ. Posterior vitreomacular adhesion and risk of 
exudative age-related macular degeneration: paired eye study. Am J 
Ophthalmol. 2009;147:621.e1–626.e1.
  25.  Waldstein SM, Sponer U, Simader C, Sacu S, Schmidt-Erfurth U. 
Influence of vitreomacular adhesion on the development of exudative 
age-related macular degeneration 4-year results of a longitudinal study. 
Retina. November 16, 2011. [Epub ahead of print.]
  26.  Mojana F, Cheng L, Bartsch DU, et al. The role of abnormal vit-
reomacular adhesion in age-related macular degeneration: spectral 
optical coherence tomography and surgical results. Am J Ophthalmol. 
2008;146:218–227.
  27.  Zweifel SA, Engelbert M, Laud K, Margolis R, Spaide RF, Freund KB. 
Outer retinal tubulation: a novel optical coherence tomography finding. 
Arch Ophthalmol. 2009;127:1596–1602.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
223
Spectral domain OCT versus time domain OCT in AMD